South Korea conducts experimental treatment on MERS-CoV patient

JUNE 17 (Eagle News) — The government of South Korea initiates the conducting of blood plasma experimental treatment on patients with Middle East Respiratory Syndrome coronavirus (MERS-CoV).

Said experimental treatment was formerly used on patients with Severe Acute Respiratory Syndrome and the results were positive resulting in a lessening of the death rate. (Seoul, South Korea)

(Eagle News Service Jay Paul Carlos, Jericho Morales, MRFaith Bonalos)

Related Post

This website uses cookies.